Influence of copper ions on uterine activity.

Abstract:

:The influence of copper ions on myometrial activity was tested in nonpregnant rabbits in vitro and in vivo, and nonpregnant women in vivo. In an organ bath, CuCl2 in concentrations of 3 micro M and higher caused a dose-dependent increase in the contractile activity of isolated rabbit myometrium. In rabbits in vivo, intrauterine instillations of 0.2 to 2 mM of CuCl2 in 0.6 ml of saline solution caused a dose-dependent increase of myometrial activity in the uterine horn where it was injected, and the response lasted up to 30 minutes. The activity in the other horn remained unchanged and control injections with saline had no effect. Also, in nonpregnant women, a clear and dose-dependent effect of 1 ml of 0.3 to 3 mM of CuCl2 dissolved in saline was observed after intrauterine instillation. Saline itself in the same volume had no effect. It is estimated that the intrauterine doses of copper which were used in these experiments lead to Cu++ concentrations in the uterine tissues which were similar to those in women carrying a copper IUD, and it is suggested that the copper from such IUDs might have effects on myometrial activity contributing to the contraceptive action and to some of the side-effects of these devices. :A study was conducted to determine the influence of copper ions in nonpregnant rabbits "in vitro" and "in vivo" and in nonpregnant women "in vivo." 25 nonpregnant does of Polish strain were housed under standardized conditions of light and feeding. Myometrium from 10 rabbits was used for "in vitro" experiments; the other animals were studied "in vivo." 6 nonpregnant, parous, and gynecologically healthy women of reproductive age participated in the study. The experiments were done within 3 days before onset of menstruation, and the recording sessions lasted for about 3 hours. In the nonpregnant rabbits "in vitro," a clear increase of the amplitude and frequency of contractions was observed with concentrations of CuC12 as low as 3 mcM in the bath fluid. An elevation of the basal tone was observed and with concentrations of 30 mcM and higher a sustained contraction generally occurred. Intravenous injections of 1 ml of CuC12 solution at a concentration of 2mcM were given to 5 rabbits "in vivo." There was no consistent effect on myometrial activity or on arterial blood pressure. A volume of 0.6 ml of saline per se had no effect on the uterine activity in 10 "in vivo" rabbits. CuC12 dissolved in the same volume of saline in concentrations of 0.2 mM resulted in an increase in uterine activity in the majority of rabbits. With 2.0 mM of CuC12 the effect was pronounced in all does. In nonpregnant women a clear and dose-dependent effect of 1 ml of 0.3-3 mM of CuC12 dissolved in saline was observed after intrauterine instillation. Saline itself in the same volume had no effect. It is estimated that the intrauterine doses of copper which were used in these experiments lead to Cu++ concentrations in the uterine tissues which were similar to those in women carrying a copper IUD. The copper from such IUDs might have effects on myometrial activity contributing to the contraceptive action and to some of the side-effects from copper IUDs.

journal_name

Contraception

journal_title

Contraception

authors

Laundański T,Kobylec E,Akerlund M

doi

10.1016/0010-7824(81)90092-5

subject

Has Abstract

pub_date

1981-08-01 00:00:00

pages

195-202

issue

2

eissn

0010-7824

issn

1879-0518

pii

0010-7824(81)90092-5

journal_volume

24

pub_type

杂志文章
  • Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.

    abstract:BACKGROUND:Women with cardiac disease have need for effective long-lasting reversible contraception. Women with cardiac disease are at increased risk for bacterial endocarditis. There is limited research regarding the use of intrauterine contraceptive devices (IUD) in women with cardiac disease. STUDY DESIGN:In a pros...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2008.05.006

    authors: Suri V,Aggarwal N,Kaur R,Chaudhary N,Ray P,Grover A

    更新日期:2008-10-01 00:00:00

  • Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.

    abstract:OBJECTIVE:Pharmacokinetics of norethindrone in combination oral contraceptive regimen are well described among HIV+ women treated with ritonavir-boosted protease inhibitor therapies; however, such characterization is lacking in women using progestin-only contraception. Our objective is to characterize pharmacokinetics ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.08.009

    authors: DuBois BN,Atrio J,Stanczyk FZ,Cherala G

    更新日期:2015-01-01 00:00:00

  • Oral contraceptives and venous thromboembolism: a five-year national case-control study.

    abstract::The objective of this study was to assess the influence of oral contraceptives (OCs) on the risk of venous thromboembolism (VTE) in young women. A 5-year case-control study including all Danish hospitals was conducted. All women 15-44 years old, suffering a first ever deep venous thrombosis or a first pulmonary emboli...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(01)00307-9

    authors: Lidegaard Ø,Edström B,Kreiner S

    更新日期:2002-03-01 00:00:00

  • Objections to tubal sterilization: what reversibility can and cannot overcome.

    abstract::In a study of 1074 women, 696 and 338 subjects would not seriously consider permanent and hypothetically reversible sterilization, respectively; they were asked to explain their feelings. The reason accounting for most objections to permanent sterilization (65%) was irreversibility and of the subjects who would not co...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(80)80001-1

    authors: Shain RN

    更新日期:1980-09-01 00:00:00

  • Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use.

    abstract:BACKGROUND:Highly effective contraception is essential in obese women, but it should not increase their risk of developing or worsening obesity-related cardiometabolic illness. The purpose of this 18-week prospective experimental study was to compare the impact of subcutaneous depot medroxyprogesterone acetate (DMPA-SC...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2011.04.016

    authors: Segall-Gutierrez P,Xiang AH,Watanabe RM,Trigo E,Stanczyk FZ,Liu X,Jurow R,Buchanan TA

    更新日期:2012-01-01 00:00:00

  • Clinical trials in male hormonal contraception.

    abstract::Research has established the principle of hormonal male contraception based on suppression of gonadotropins and spermatogenesis. All hormonal male contraceptives use testosterone, but only in East Asian men can testosterone alone suppress spermatogenesis to a level compatible with contraceptive protection. In Caucasia...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2010.03.020

    authors: Nieschlag E

    更新日期:2010-11-01 00:00:00

  • Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.

    abstract::A prospective randomized trial was conducted in 140 women to compare the efficacy of vaginal gemeprost with vaginal misoprostol for termination of second trimester pregnancy. Women requesting termination of second trimester pregnancy were randomized into two groups. Group A women were given 1 mg vaginal gemeprost ever...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(98)00099-7

    authors: Wong KS,Ngai CS,Wong AY,Tang LC,Ho PC

    更新日期:1998-10-01 00:00:00

  • Intraoperative placement of the Copper T-380 intrauterine devices in women undergoing elective cesarean delivery: a pilot study.

    abstract:BACKGROUND:The purpose of this pilot project was to test the feasibility of a technique designed to place a copper intrauterine device (IUD) through the hysterotomy incision of an elective cesarean delivery to minimize possible contamination and to guarantee that tailstrings were visible in the vagina for easy removal ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2009.01.014

    authors: Nelson AL,Chen S,Eden R

    更新日期:2009-07-01 00:00:00

  • Induction of menstruation by antiprogesterone ZK 98.299 in cycling bonnet monkeys.

    abstract::The antiprogestin ZK 98.299 (11 beta-(4-dimethylaminophenyl)-17 alpha-hydroxy-17 beta-(3-hydroxypropyl)-13 alpha-methyl-4,9-gonadien-3-one) was administered s.c. (30mg/day) to two groups of cycling bonnet monkeys. In Group I (n = 6), it was injected from day 16 to 18 and in Group II (n = 9) from day 21 to 23 of the cy...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(87)90077-1

    authors: Puri CP,Elger WG,Pongubala JM

    更新日期:1987-04-01 00:00:00

  • Further studies on pituitary and ovarian function in women receiving hormonal contraception.

    abstract::Pituitary and ovarian function was evaluated in women receiving 3 combined oral contraceptive preparations. Basal levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) and gonadotropic responses to gonadotropic releasing hormone (GnRH) were studied in 36 healthy, regularly ovulating women in the ea...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(81)90089-5

    authors: Cohen BL,Katz M

    更新日期:1981-08-01 00:00:00

  • Medication Abortion Up to 70 Days of Gestation.

    abstract::Medication abortion, also referred to as medical abortion, is a safe and effective method of providing abortion. Medication abortion involves the use of medicines rather than uterine aspiration to induce an abortion. The U.S. Food and Drug Administration (FDA)-approved medication abortion regimen includes mifepristone...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.08.004

    authors: Practice Bulletins—Gynecology, the Society of Family Planning.

    更新日期:2020-10-01 00:00:00

  • Cell-cell interactions in the local control of seminiferous tubule contractility.

    abstract::Since peritubular smooth muscle cells (PSMCs) have been characterized, isolated and cultured in homogeneous populations, the regulation of seminiferous epithelium contractility has received increasing attention. The present article reports and discusses experimental evidence demonstrating that: (1) PSMCs express two t...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/s0010-7824(01)00319-5

    authors: Palombi F,Filippini A,Chiarenza C

    更新日期:2002-04-01 00:00:00

  • Comparison of remote and in-clinic follow-up after methotrexate/misoprostol abortion.

    abstract:OBJECTIVE:This study compared adherence to follow-up and clinical outcomes between standard in-clinic and remote follow-up after methotrexate/misoprostol abortion. STUDY DESIGN:This nonrandomized trial recruited women requesting medical abortion at two sexual health clinics in Toronto, Canada. Women received methotrex...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2015.05.013

    authors: Dunn S,Panjwani D,Gupta M,Meaney C,Morgan R,Feuerstein E

    更新日期:2015-09-01 00:00:00

  • The zoapatle V--the effect of kauradienoic acid upon uterine contractility.

    abstract::Kauradienoic acid was obtained from the hexanic extract of M. tomentosa (Cerv) leaves by chromatographic separation. This substance influenced the in vitro contractility of the rat, dog and guinea pig uterine strips. It also induced strong contractions of the guinea pig uterus in vivo when administered intravenously, ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90005-7

    authors: Lozoya X,Enríquez RG,Bejar E,Estrada AV,Girón H,Ponce-Monter H,Gallegos AJ

    更新日期:1983-03-01 00:00:00

  • Effectiveness of a theory-based postpartum sexual health education program on women's contraceptive use: a randomized controlled trial.

    abstract:BACKGROUND:The aim of this study was to evaluate the effectiveness of a refined theory-based Interactive Postpartum Sexual Health Education Program to enhance postpartum women's effective contraceptive behavior. STUDY DESIGN:Participants (N=250) were randomized to three groups. Experimental Group A received our interv...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2010.11.008

    authors: Lee JT,Tsai JL,Tsou TS,Chen MC

    更新日期:2011-07-01 00:00:00

  • Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women.

    abstract::RU 486 and three of its metabolites (RU 42633-monodemethyl, RU 42848-didemethyl, and RU 42698-hydroxymetabolite) were determined by HPLC in plasma from nine non-pregnant and 36 pregnant women. Each non-pregnant subject took an oral dose of RU 486 (25, 100, 400 and 600 mg consecutively) once per menstrual cycle. Six of...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(93)90004-q

    authors: Shi YE,Ye ZH,He CH,Zhang GQ,Xu JQ,Van Look PF,Fotherby K

    更新日期:1993-08-01 00:00:00

  • Postovulatory contraception in women with large doses of norethindrone.

    abstract::To test the contraceptive efficacy of norethindrone (NET), the effect of NET on peripheral plasma levels of progesterone and estradiol after ovulation was investigated, since low levels of ovarian steroids might affect the postovulatory endometrium and thereby impair normal blastocyst implantation. Two studies were ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(72)90011-x

    authors: Nygren KG,Johansson ED,Wide L

    更新日期:1972-06-01 00:00:00

  • Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.

    abstract:OBJECTIVE:The aim of this study was to assess the presence of ovarian cysts in women using a new low-dose levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 13.5mg [total content]). STUDY DESIGN:A Phase 3 study assessed LNG-IUS 13.5mg use in healthy women with regular menstrual cycles who requested co...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.contraception.2015.01.021

    authors: Nahum GG,Kaunitz AM,Rosen K,Schmelter T,Lynen R

    更新日期:2015-05-01 00:00:00

  • The benefits of family planning training: a 10-year review of the Ryan Residency Training Program.

    abstract:OBJECTIVE:The objective was to determine the effect of routine, opt-out abortion and family planning training on clinical exposure to uterine evacuation, contraception and other gynecologic skills. METHODS:Data from the first 10 years of the Kenneth J. Ryan Residency Training Program in Abortion and Family Planning we...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2013.02.006

    authors: Steinauer JE,Turk JK,Fulton MC,Simonson KH,Landy U

    更新日期:2013-08-01 00:00:00

  • Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.

    abstract::9-Deoxo-16, 16-dimethyl-9-methylene-PGE2 is a new prostaglandin analogue which is stable in suppository form. Estimates of potential for gastrointestinal side effects in monkey in vivo indicated that the frequency of diarrhea was low with retention of uterine stimulating potency. In the present study the effect of the...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90059-1

    authors: Bygdeman M,Christensen N,Gréen K,Lundström V

    更新日期:1980-08-01 00:00:00

  • Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.

    abstract:BACKGROUND:Women with depressive or bipolar disorders are at an increased risk for unintended pregnancy. OBJECTIVE:To examine the safety of hormonal contraception among women with depressive and bipolar disorders. METHODS:We searched for articles published through January 2016 on the safety of using any hormonal cont...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.06.012

    authors: Pagano HP,Zapata LB,Berry-Bibee EN,Nanda K,Curtis KM

    更新日期:2016-12-01 00:00:00

  • Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.

    abstract::Fifty-six women using depot-norethisterone enanthate injections for contraception for 2 years or more were compared with a control group of 48 women not using hormonal contraception. No significant difference was found between the study group and controls for Factors VIIc and Antithrombin III. Factor Xc was reduced in...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(91)90083-r

    authors: McEwan JA,Griffin M

    更新日期:1991-12-01 00:00:00

  • Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel.

    abstract::In a cross-over study with orally administered desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) and 3-keto-desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) in ten women under steady-state conditions, the serum levels of 3-keto-desogestrel were monitored by radioimmunoassay. No statistically significant...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(86)90047-8

    authors: Hasenack HG,Bosch AM,Käär K

    更新日期:1986-06-01 00:00:00

  • Comparing abortion induced with methotrexate and misoprostol to methotrexate alone.

    abstract::This was a dual-cohort study performed to determine if, by using methotrexate alone, abortions could be induced with fewer side effects, without sacrificing effectiveness and patient satisfaction. The subjects were 358 consecutive patients who requested elective medical termination of pregnancy at < 7 weeks gestation....

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(98)00146-2

    authors: Wiebe ER

    更新日期:1999-01-01 00:00:00

  • Menstrual blood loss estimates in women using copper 7 and multiload-250 intrauterine devices.

    abstract::An estimate of the menstrual blood loss (MBL) in 29 women using the Cu-7 and in 33 women using the ML-250 IUDs was carried out. None of the women who took part in the study used hormonal contraceptives or IUDs for six months previous to the study. Before the insertion of the IUD, the MBL of each woman was measured for...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(82)90146-9

    authors: Pedrón N,Gallegos AJ,Lozano M,Aznar R

    更新日期:1982-11-01 00:00:00

  • Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects.

    abstract::Levels of immunoreactive follitropin (FSH), lutropin (LH), estradiol, progesterone, 17-hydroxyprogesterone and 20 alpha-dihydroprogesterone were analyzed in peripheral plasma samples collected daily from 21 normally menstruating women during a pretreatment (control) cycle and during months 2 and 6 of administration of...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(81)90049-4

    authors: Landgren BM,Lager S,Diczfalusy E

    更新日期:1981-03-01 00:00:00

  • Effect of polyphloretin phosphate on the contraceptive action of a polyethylene intrauterine device in rats.

    abstract::A polyethylene intrauterine device (IUD) inserted in one horn of the rat uterus on Day 2 of pregnancy prevented implantation in 9 out of 12 rats in the horn with the device. When polyphloretin phosphate (PPP), a substance known to inhibit alkaline phosphatase, was administered to such rats from Day 1 till Day 5 of pre...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90016-1

    authors: Chaudhury MR

    更新日期:1983-08-01 00:00:00

  • A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.

    abstract::A randomised cross-over trial was performed to compare the pharmacodynamic actions of three low-dose oral contraceptives (OCs): Marvelon (150 micrograms desogestrel (DSG)+ 30 micrograms ethinyloestradiol (EE)), Mercilon (150 micrograms DSG + 20 micrograms EE) and Microgynon (150 micrograms levonorgestrel (LNG) + 30 mi...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(92)90103-z

    authors: Song S,Chen JK,Yang PJ,He ML,Li LM,Fan BC,Rekers H,Fotherby K

    更新日期:1992-06-01 00:00:00

  • Response to requests for contraception in one direct-to-consumer telemedicine service.

    abstract:OBJECTIVE:To describe real-world care seeking and contraception provision in one direct to consumer telemedicine platform. STUDY DESIGN:We described encounters with reproductive age female patients between July 2016 and July 2018 seeking contraception on the American Well telemedicine platform. RESULTS:Of 126,712 tot...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.01.017

    authors: Martinez KA,Rastogi R,Lipold L,Rothberg MB

    更新日期:2020-05-01 00:00:00

  • Disparities in contraceptive knowledge, attitude and use between Hispanic and non-Hispanic whites.

    abstract:BACKGROUND:Higher rates of unwanted pregnancies and lower rates of contraceptive use have been reported among Hispanic women than among non-Hispanic whites. Despite these differences, it is unclear how these groups differ with respect to various psychosocial factors that are associated with contraceptive decision makin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.02.010

    authors: Sangi-Haghpeykar H,Ali N,Posner S,Poindexter AN

    更新日期:2006-08-01 00:00:00